Trademarkia Logo

Canada

C$
AVENKEN
ADVERTISED

on 19 Feb 2025

Last Applicant/ Owned by

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee51373 Leverkusen

DE

Serial Number

2237236 filed on 10th Jan 2023

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

AVENKEN

Trademark usage description

pharmaceutical preparations for humans for the treatment of gynecological diseases and disorders, namely, amenorrhoea, dysmenorrhea, menorrhagia, gyne Read More

Classification Information


Class [005]
Pharmaceutical preparations for humans for the treatment of gynecological diseases and disorders, namely, amenorrhoea, dysmenorrhea, menorrhagia, gynecologic cancer, endometrial hyperplasia, endometriosis, endometritis, menstrual disorders, premenstrual syndrome, inflammatory pelvic diseases, pelvic pain, infections of the vagina, cervix and uterus, infertility, sexually transmitted diseases, sexual dysfunction, and menopausal vasomotor symptoms (VMS) to decrease night sweats and hot flashes and improve sleep quality; pharmaceutical preparations for humans for the treatment of hormonal diseases, disorders and deficiencies.


Classification kind code

12

Mark Details


Serial Number

2237236

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 10th May 2024
Agent Changed
Submitted for opposition 22
on 3rd May 2024
Search Recorded
Submitted for opposition 20
on 3rd May 2024
Examiner's First Report
Submitted for opposition 223
on 3rd May 2024
Total Provisional Refusal
Submitted for opposition 256
on 4th Dec 2023
Notification of Possible Opposition Sent
Submitted for opposition 257
on 2th Feb 2023
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 1st Feb 2023
Created
Submitted for opposition 31
on 1st Feb 2023
Formalized
Submitted for opposition 30
on 10th Jan 2023
Filed
Submitted for opposition 228
on 10th Jan 2023
International Registration